Deborah Schrag, M.D., M.P.H., Dana-Farber Cancer Institute […]
Videos: JAMA Theme Issue on Comparative Effectiveness Research
Adil H. Haider, M.D., M.P.H., F.A.C.S., Johns Hopkins University School of Medicine […]
Videos: JAMA Theme Issue on Comparative Effectiveness Research
Ronald C. Chen, M.D., M.P.H., University of North Carolina at Chapel Hill […]
Videos: JAMA Theme Issue on Comparative Effectiveness Research
Anne C. Beal, M.D., M.P.H., Patient-Centered Outcomes Research Institute […]
Comparative Effectiveness Research Collaborative Initiative – Presentation from ISPOR DC
Is it possible to efficiently generate and interpret CER for newly marketed drugs in time?
Kristijan H. Kahler, PhD, RPh, Executive Director, Outcomes Research Methods & Analytics, Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, ISPOR Washington DC, 2012. […]
Principles for Planning and Conducting Comparative Effectiveness Research
A set of 13 best practice principles developed by a group of leading researchers could help to ensure more consistency in how comparative effectiveness research (CER) is conducted and applied in real world situations. These guiding principles were published as part of peer-reviewed study in the […]
Incentivizing Comparative Effectiveness Research
Provides an overview and analysis of public funding of CER and the desirability and feasibility of incentivizing additional CER in the private sector. […]
The Promise of Comparative-Effectiveness Research: Empowering Patients and Providers
[…]
The Problems of Comparative Effectiveness Research
Advocates of CER often say their goal is to find and encourage what is best for patients, and certainly CER can be used in this way. But when the data gathered is used by government agencies to lower spending - such as by favoring older, cheaper drugs over newer, more expensive ones, as has been the […]
What Did Our Panelists Say at ISPOR on RCTs vs. Observational Studies?
Insight into the reasons for choosing one type of comparative effectiveness research study design over another. (Source: 5/24, National Pharmaceutical Council: E.V.I.dently Today) […]
Comparative Effectiveness Research: Evaluating the Flashy New Car(e)
Why do we expect government to pay for drugs and a whole menu of medical interventions that are no better at securing health than the older alternatives they seek to replace? The burden of evidence must be on innovation to explicitly prove its worth...Without research into the comparative […]
Comparative Effectiveness Database
The National Patient Advocate Foundation has launched a comparative-effectiveness research database (PDF) that compiles research funded by the National Institutes of Health and the Agency for Healthcare Research and Quality...The database was launched with information on 224 NIH research projects; a […]
FDAs Initial CER Studies to Develop Trial Designs and Analytic Software
Hierarchies of Evidence for Comparative Effectiveness – Reinforced by Unequal Quality of Publications?
Observational Methods in Comparative Effectiveness Research
Comparative effectiveness research (CER) may be defined informally as an assessment of available options for treating specific medical conditions in selected groups of patients. In this context, the most prominent features of CER are the various patient populations, medical ailments, and treatment […]
How Physicians Can Drive Comparative-effectiveness Research: Lessons from New Zealand
This role and how physicians might be involved in comparative-effectiveness research are important considerations. As front-line service providers, physicians have a considerable stake in how comparative-effectiveness research mechanisms are constructed, in leading collegial buy-in to associated […]
O Say Can You C(ER) – An Inventory Of Comparative Effectiveness Research Capacity In The HMO Research Network
The HMO Research Network (HMORN) is uniquely positioned to conduct Comparative Effectiveness Research (CER). The 2009 health care reform debate; Recovery Act legislation and funding mandates; the Institute of Medicine (IOM) report of Initial National Priorities for Comparative Effectiveness Research […]
RCTs vs Observational Studies: The Next Great Debate in CER
Comparative Effectiveness Research: Do Employers Care? What Will They Do?
Attitudes of employers on comparative effectiveness research. […]
The State of Comparative Effectiveness Research and the Environment for Decision Making
Utilizing Health Outcomes Data to Drive Company Decision-Making: Interview With Kevin Mayo
Interview covering trends and major challenges in HEOR. […]
Comparative Cost Effectiveness and Value-Based Purchasing: Why the Pharmaceutical and Medical-Surgical Device Industries Are Embracing the Coming Market Evolution
By Josh Feldstein. This white paper examines key factors in CER, and makes specific recomendations. […]
How Comparative Effectiveness Feeds into Cost-Benefit Analysis by Kevin D. Frick PhD
The author relates CER to CBA, and discusses why CER research design is easier to translate into CBA than randomized controlled trials. […]
AHEOR Media Library
PowerPoint Presentation by Dr. Joe Jackson,Applied Health Outcomes Research at Thomas Jefferson University. Proponents of Comparative Effectiveness Research (CER) hope to challenge conventional thinking in evidence-based medicine, observational research design, patient-centered aspects in medical […]
Comparative Effectiveness Analysis Using Simulated Treatment Comparison, PPT by L. Eckert
Presentation at ISPOR Europe, Nov. 2011 by Laurent Eckert, PhD, sanofi-aventis R&D, Massy, France […]
Designing Better Comparative Effectiveness Research, PPT by R. Gliklich
Presentation at ISPOR Europe, Nov. 2011 by Richard Gliklich, MD, President & CEO, Outcome, Cambridge, MA, USA; Newell McElwee, PharmD, MSPH, Exec Director, US Outcomes Research, Merck , North Wales, PA, USA; Donna Messner, PhD, Senior Project Manager, Center for Medical Technology Policy, […]
Comparative Effectiveness Research Primer Presentation.
GRACE Principles: good practice for the design, conduct, analysis, and reporting of observational CER studies
Designed as a set of high-level questions, the GRACE Principles address good practice for the design, conduct, analysis, and reporting of observational CER studies. These principles may be expanded to provide more detail and/or to address special applications. […]
Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “Real-World Data”.
JMCP Supplement. Includes Ten Commandments for CER, secondary data structures, stat issues, developing collaborative study protocol, and more. […]
